Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus

NCT06855615 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER_GOV

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Mixtard® 30 TDS
DRUG: Insulatard® once daily and thrice daily prandial Actrapid®

Sponsor

Hospital Sultanah Aminah Johor Bahru

Collaborators

[object Object]